20 results on '"Tumba, Nancy"'
Search Results
2. Potent and broad HIV-neutralizing antibodies in memory B cells and plasma
- Author
-
Williams, LaTonya D., Ofek, Gilad, Schätzle, Sebastian, McDaniel, Jonathan R., Lu, Xiaozhi, Nicely, Nathan I., Wu, Liming, Lougheed, Caleb S., Bradley, Todd, Louder, Mark K., McKee, Krisha, Bailer, Robert T., O’Dell, Sijy, Georgiev, Ivelin S., Seaman, Michael S., Parks, Robert J., Marshall, Dawn J., Anasti, Kara, Yang, Guang, Nie, Xiaoyan, Tumba, Nancy L., Wiehe, Kevin, Wagh, Kshitij, Korber, Bette, Kepler, Thomas B., Munir Alam, S., Morris, Lynn, Kamanga, Gift, Cohen, Myron S., Bonsignori, Mattia, Xia, Shi-Mao, Montefiori, David C., Kelsoe, Garnett, Gao, Feng, Mascola, John R., Moody, M. Anthony, Saunders, Kevin O., Liao, Hua-Xin, Tomaras, Georgia D., Georgiou, George, and Haynes, Barton F.
- Published
- 2017
- Full Text
- View/download PDF
3. Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics
- Author
-
Tumba, Nancy L., primary, Naicker, Previn, additional, Stoychev, Stoyan, additional, Killick, Mark A., additional, Owen, Gavin R., additional, and Papathanasopoulos, Maria A., additional
- Published
- 2022
- Full Text
- View/download PDF
4. Structure and immune recognition of trimeric pre-fusion HIV-1 Env
- Author
-
Pancera, Marie, Zhou, Tongqing, Druz, Aliaksandr, Georgiev, Ivelin S., Soto, Cinque, Gorman, Jason, Huang, Jinghe, Acharya, Priyamvada, Chuang, Gwo-Yu, Ofek, Gilad, Stewart-Jones, Guillaume B.E., Stuckey, Jonathan, Bailer, Robert T., Joyce, M. Gordon, Louder, Mark K., Tumba, Nancy, Yang, Yongping, Zhang, Baoshan, Cohen, Myron S., Haynes, Barton F., Mascola, John R., Morris, Lynn, Munro, James B., Blanchard, Scott C., Mothes, Walther, Connors, Mark, and Kwong, Peter D.
- Subjects
HIV antibodies -- Physiological aspects ,Viral proteins -- Structure -- Health aspects ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
The human immunodeficiency virus type 1 (HIV-1) envelope (Env) spike, comprising three gp120 and three gp41 sub-units, is a conformational machine that facilitates HIV-1 entry by rearranging from a mature unliganded state, through receptor-bound intermediates, to a post-fusion state. As the sole viral antigen on the HIV-1 virion surface, Env is both the target of neutralizing antibodies and a focus of vaccine efforts. Here we report the structure at 3.5 A resolution for an HIV-1 Env trimer captured in a mature closed state by antibodies PGT122 and 35O22. This structure reveals the prefusion conformation of gp41, indicates rearrangements needed for fusion activation, and defines parameters of immune evasion and immune recognition. Pre-fusion gp41 encircles amino- and carboxy- terminal strands of gp120 with four helices that form a membrane-proximal collar, fastened by insertion of a fusion peptide-proximal methionine into a gp41-tryptophan clasp. Spike rearrangements required for entry involve opening the clasp and expelling the termini. N-linked glycosylation and sequence- variable regions cover the pre-fusion closed spike; we used chronic cohorts to map the prevalence and location of effective HIV-1-neutralizing responses, which were distinguished by their recognition of N-linked glycan and tolerance for epitope-sequence variation., Over the last 50 years, more than 70 million people have been infected or killed by the human immunodeficiency virus type 1 (HIV-1) (1). A dominant contributing factor has been [...]
- Published
- 2014
- Full Text
- View/download PDF
5. Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape
- Author
-
Moore, Penny L., Gray, Elin S., Wibmer, C. Kurt, Bhiman, Jinal N., Nonyane, Molati, Sheward, Daniel J., Hermanus, Tandile, Bajimaya, Shringkhala, Tumba, Nancy L., Abrahams, Melissa-Rose, Lambson, Bronwen E., Ranchobe, Nthabeleng, Ping, Lihua, Ngandu, Nobubelo, Karim, Quarraisha Abdool, Karim, Salim S. Abdool, Swanstrom, Ronald I., Seaman, Michael S., Williamson, Carolyn, and Morris, Lynn
- Subjects
Viral antibodies -- Physiological aspects -- Genetic aspects -- Research ,Antigenic determinants -- Physiological aspects -- Genetic aspects -- Research ,Antibodies -- Physiological aspects -- Genetic aspects -- Research ,HIV infection -- Genetic aspects -- Prevention -- Research ,Biological sciences ,Health - Abstract
Neutralizing antibodies are likely to play a crucial part in a preventative HIV-1 vaccine. Although efforts to elicit broadly cross-neutralizing (BCN) antibodies by vaccination have been unsuccessful (1-3), a minority of individuals naturally develop these antibodies after many years of infection (4-7). How such antibodies arise, and the role of viral evolution in shaping these responses, is unknown. Here we show, in two HIV-1-infected individuals who developed BCN antibodies targeting the glycan at Asn332 on the gp120 envelope, that this glycan was absent on the initial infecting virus. However, this BCN epitope evolved within 6 months, through immune escape from earlier strain-specific antibodies that resulted in a shift of a glycan to position 332. Both viruses that lacked the glycan at amino acid 332 were resistant to the Asn332-dependent BCN monoclonal antibody PGT128 (ref. 8), whereas escaped variants that acquired this glycan were sensitive. Analysis of large sequence and neutralization data sets showed the 332 glycan to be significantly under-represented in transmitted subtype C viruses compared to chronic viruses, with the absence of this glycan corresponding with resistance to PGT128. These findings highlight the dynamic interplay between early antibodies and viral escape in driving the evolution of conserved BCN antibody epitopes., Although the role of glycans in shielding neutralizing epitopes has long been known (9-11), it has only recently become clear that many BCN responses directly target glycans, including the one [...]
- Published
- 2012
- Full Text
- View/download PDF
6. Comparative analysis of expression and secretion of placental leptin in mammals
- Author
-
Zhao, Jing, Kunz, Thomas H., Tumba, Nancy, Schulz, Laura Clamon, Li, Chris, Reeves, Monica, and Widmaier, Eric P.
- Subjects
Homeostasis -- Research ,Leptin -- Research ,Biological sciences - Abstract
Increased plasma level of leptin appears to be a ubiquitous feature of pregnant mammals. The mechanisms by which leptin levels are increased may be species specific, however, with some species upregulating adipose leptin production and others expressing leptin in the placenta. Placental leptin expression was examined in representative species of the two most abundant mammalian orders, Rodentia and Chiroptera, and in cultured human choriocarcinoma (BeWo) cells. Leptin mRNA was expressed in BeWo cells and in placentas of Myotis lucifugus (little brown bat), Eptesicus fuscus (big brown bat), and Rattus norvegicus (laboratory rat), but not the common laboratory mouse Mus musculus, cAMP stimulated secretion of leptin from BeWo cells and also stimulated leptin mRNA expression in the cells. In addition to adipose and placental tissue, leptin transcript in M. lucifugus was detectable in heart, spleen, and liver, but not in lung, brain, and kidney. Hepatic expression was also observed in E. fuscus, but not in mice or rats, and did not appear to result from hepatic fat deposition. Leptin cDNA was cloned and sequenced from M. lucifugus placenta and shared up to 95% homology with other mammalian leptin cDNAs. It is concluded that 1) placental leptin expression and secretion are species-specific traits, 2) placental leptin production represents one of three major mechanisms for achieving high circulating maternal leptin levels during pregnancy, the others being upregulation of adipose leptin production and production of circulating leptin-binding proteins, and 3) hepatic leptin expression in pregnant insectivorous bats may be an adaptation resulting from the presence of extremely low amounts of subcutaneous fat during pregnancy and lactation in these species. bats; adipose tissue; energy homeostasis; reproduction; placenta
- Published
- 2003
7. Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization
- Author
-
Rademeyer, Cecilia, primary, Korber, Bette, additional, Seaman, Michael S., additional, Giorgi, Elena E., additional, Thebus, Ruwayhida, additional, Robles, Alexander, additional, Sheward, Daniel J., additional, Wagh, Kshitij, additional, Garrity, Jetta, additional, Carey, Brittany R., additional, Gao, Hongmei, additional, Greene, Kelli M., additional, Tang, Haili, additional, Bandawe, Gama P., additional, Marais, Jinny C., additional, Diphoko, Thabo E., additional, Hraber, Peter, additional, Tumba, Nancy, additional, Moore, Penny L., additional, Gray, Glenda E., additional, Kublin, James, additional, McElrath, M. Juliana, additional, Vermeulen, Marion, additional, Middelkoop, Keren, additional, Bekker, Linda-Gail, additional, Hoelscher, Michael, additional, Maboko, Leonard, additional, Makhema, Joseph, additional, Robb, Merlin L., additional, Karim, Salim Abdool, additional, Karim, Quarraisha Abdool, additional, Kim, Jerome H., additional, Hahn, Beatrice H., additional, Gao, Feng, additional, Swanstrom, Ronald, additional, Morris, Lynn, additional, Montefiori, David C., additional, and Williamson, Carolyn, additional
- Published
- 2017
- Full Text
- View/download PDF
8. Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity
- Author
-
Bradley, Todd, primary, Trama, Ashley, additional, Tumba, Nancy, additional, Gray, Elin, additional, Lu, Xiaozhi, additional, Madani, Navid, additional, Jahanbakhsh, Fatemeh, additional, Eaton, Amanda, additional, Xia, Shi-Mao, additional, Parks, Robert, additional, Lloyd, Krissey E., additional, Sutherland, Laura L., additional, Scearce, Richard M., additional, Bowman, Cindy M., additional, Barnett, Susan, additional, Abdool-Karim, Salim S., additional, Boyd, Scott D., additional, Melillo, Bruno, additional, Smith, Amos B., additional, Sodroski, Joseph, additional, Kepler, Thomas B., additional, Alam, S.Munir, additional, Gao, Feng, additional, Bonsignori, Mattia, additional, Liao, Hua-Xin, additional, Moody, M. Anthony, additional, Montefiori, David, additional, Santra, Sampa, additional, Morris, Lynn, additional, and Haynes, Barton F., additional
- Published
- 2016
- Full Text
- View/download PDF
9. Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization
- Author
-
Rademeyer, Cecilia, primary, Korber, Bette, additional, Seaman, Michael S., additional, Giorgi, Elena E., additional, Thebus, Ruwayhida, additional, Robles, Alexander, additional, Sheward, Daniel J., additional, Wagh, Kshitij, additional, Garrity, Jetta, additional, Carey, Brittany R., additional, Gao, Hongmei, additional, Greene, Kelli M., additional, Tang, Haili, additional, Bandawe, Gama P., additional, Marais, Jinny C., additional, Diphoko, Thabo E., additional, Hraber, Peter, additional, Tumba, Nancy, additional, Moore, Penny L., additional, Gray, Glenda E., additional, Kublin, James, additional, McElrath, M. Juliana, additional, Vermeulen, Marion, additional, Middelkoop, Keren, additional, Bekker, Linda-Gail, additional, Hoelscher, Michael, additional, Maboko, Leonard, additional, Makhema, Joseph, additional, Robb, Merlin L., additional, Abdool Karim, Salim, additional, Abdool Karim, Quarraisha, additional, Kim, Jerome H., additional, Hahn, Beatrice H., additional, Gao, Feng, additional, Swanstrom, Ronald, additional, Morris, Lynn, additional, Montefiori, David C., additional, and Williamson, Carolyn, additional
- Published
- 2016
- Full Text
- View/download PDF
10. Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses
- Author
-
Moody, M. Anthony, primary, Gao, Feng, additional, Gurley, Thaddeus C., additional, Amos, Joshua D., additional, Kumar, Amit, additional, Hora, Bhavna, additional, Marshall, Dawn J., additional, Whitesides, John F., additional, Xia, Shi-Mao, additional, Parks, Robert, additional, Lloyd, Krissey E., additional, Hwang, Kwan-Ki, additional, Lu, Xiaozhi, additional, Bonsignori, Mattia, additional, Finzi, Andrés, additional, Vandergrift, Nathan A., additional, Alam, S. Munir, additional, Ferrari, Guido, additional, Shen, Xiaoying, additional, Tomaras, Georgia D., additional, Kamanga, Gift, additional, Cohen, Myron S., additional, Sam, Noel E., additional, Kapiga, Saidi, additional, Gray, Elin S., additional, Tumba, Nancy L., additional, Morris, Lynn, additional, Zolla-Pazner, Susan, additional, Gorny, Miroslaw K., additional, Mascola, John R., additional, Hahn, Beatrice H., additional, Shaw, George M., additional, Sodroski, Joseph G., additional, Liao, Hua-Xin, additional, Montefiori, David C., additional, Hraber, Peter T., additional, Korber, Bette T., additional, and Haynes, Barton F., additional
- Published
- 2015
- Full Text
- View/download PDF
11. Glutamine synthetase in Bacteroides fragilis
- Author
-
Tumba, Nancy and Abratt, Valerie Rose
- Subjects
Molecular and Cell Biology - Abstract
Includes bibliographical references (p. 78-90)., Bactereroides fragilis is a gram-negative, non spore-forming, obligate anaerobe of the human intestinal microbiota. It is, however, an opportunistic pathogen and has been ranked as the most prevalent isolate in cases of anaerobic septicaemia. Similar to most bacteria, ammonium is assimilated in B. fragilis through the action of glutamine synthetase (GS). Glutamine is vital to nitrogen metabolism as it serves as a precursor to many secondary metabolites. GS enzymes are, therefore, vital to the growth of the organism and many prokaryotes are known to possess two or more isoforms of the enzyme. In addition, GS expression and regulation is usually tightly regulated in concert with the availability of nitrogen. Previous studies have identified a single GSIII encoding gene (glnN) in B. fragilis. In this dissertation, an additional ORF coding for a putative GSI enzyme in B. fragilis was identified, isolated and functionally characterized. A putative regulatory protein was also identified and its functional contribution to nitrogen metabolism was determined, in order to extend our understanding of nitrogen assimilation in B. fragilis.
- Published
- 2007
12. A Fusion Intermediate gp41 Immunogen Elicits Neutralizing Antibodies to HIV-1
- Author
-
Lai, Rachel P.J., primary, Hock, Miriam, additional, Radzimanowski, Jens, additional, Tonks, Paul, additional, Hulsik, David Lutje, additional, Effantin, Gregory, additional, Seilly, David J., additional, Dreja, Hanna, additional, Kliche, Alexander, additional, Wagner, Ralf, additional, Barnett, Susan W., additional, Tumba, Nancy, additional, Morris, Lynn, additional, LaBranche, Celia C., additional, Montefiori, David C., additional, Seaman, Michael S., additional, Heeney, Jonathan L., additional, and Weissenhorn, Winfried, additional
- Published
- 2014
- Full Text
- View/download PDF
13. Viral Escape From HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition Of Multiple Epitopes And Immunotypes
- Author
-
Wibmer, Constantinos K., Bhiman, Jinal N., Gray, Elin S., Tumba, Nancy, Abdool Karim, Salim S, Williamson, Carolyn, Morris, Lynn, Moore, Penny L., Wibmer, Constantinos K., Bhiman, Jinal N., Gray, Elin S., Tumba, Nancy, Abdool Karim, Salim S, Williamson, Carolyn, Morris, Lynn, and Moore, Penny L.
- Abstract
Identifying the targets of broadly neutralizing antibodies to HIV-1 and understanding how these antibodies develop remain important goals in the quest to rationally develop an HIV-1 vaccine. We previously identified a participant in the CAPRISA Acute Infection Cohort (CAP257) whose plasma neutralized 84% of heterologous viruses. In this study we showed that breadth in CAP257 was largely due to the sequential, transient appearance of three distinct broadly neutralizing antibody specificities spanning the first 4.5 years of infection. The first specificity targeted an epitope in the V2 region of gp120 that was also recognized by strain-specific antibodies 7 weeks earlier. Specificity for the autologous virus was determined largely by a rare N167 antigenic variant of V2, with viral escape to the more common D167 immunotype coinciding with the development of the first wave of broadly neutralizing antibodies. Escape from these broadly neutralizing V2 antibodies through deletion of the glycan at N160 was associated with exposure of an epitope in the CD4 binding site that became the target for a second wave of broadly neutralizing antibodies. Neutralization by these CD4 binding site antibodies was almost entirely dependent on the glycan at position N276. Early viral escape mutations in the CD4 binding site drove an increase in wave two neutralization breadth, as this second wave of heterologous neutralization matured to recognize multiple immunotypes within this site. The third wave targeted a quaternary epitope that did not overlap any of the four known sites of vulnerability on the HIV-1 envelope and remains undefined. Altogether this study showed that the human immune system is capable of generating multiple broadly neutralizing antibodies in response to a constantly evolving viral population that exposes new targets as a consequence of escape from earlier neutralizing antibodies.
- Published
- 2013
14. Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes
- Author
-
Wibmer, Constantinos Kurt, primary, Bhiman, Jinal N., additional, Gray, Elin S., additional, Tumba, Nancy, additional, Abdool Karim, Salim S., additional, Williamson, Carolyn, additional, Morris, Lynn, additional, and Moore, Penny L., additional
- Published
- 2013
- Full Text
- View/download PDF
15. UCLA1, a Synthetic Derivative of a gp120 RNA Aptamer, Inhibits Entry of Human Immunodeficiency Virus Type 1 Subtype C
- Author
-
Mufhandu, Hazel T., primary, Gray, Elin S., additional, Madiga, Maphuti C., additional, Tumba, Nancy, additional, Alexandre, Kabamba B., additional, Khoza, Thandeka, additional, Wibmer, Constantinos Kurt, additional, Moore, Penny L., additional, Morris, Lynn, additional, and Khati, Makobetsa, additional
- Published
- 2012
- Full Text
- View/download PDF
16. Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals
- Author
-
Tomaras, Georgia D., primary, Binley, James M., additional, Gray, Elin S., additional, Crooks, Emma T., additional, Osawa, Keiko, additional, Moore, Penny L., additional, Tumba, Nancy, additional, Tong, Tommy, additional, Shen, Xiaoying, additional, Yates, Nicole L., additional, Decker, Julie, additional, Wibmer, Constantinos Kurt, additional, Gao, Feng, additional, Alam, S. Munir, additional, Easterbrook, Philippa, additional, Abdool Karim, Salim, additional, Kamanga, Gift, additional, Crump, John A., additional, Cohen, Myron, additional, Shaw, George M., additional, Mascola, John R., additional, Haynes, Barton F., additional, Montefiori, David C., additional, and Morris, Lynn, additional
- Published
- 2011
- Full Text
- View/download PDF
17. Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop
- Author
-
Moore, Penny L., primary, Gray, Elin S., additional, Sheward, Daniel, additional, Madiga, Maphuti, additional, Ranchobe, Nthabeleng, additional, Lai, Zhong, additional, Honnen, William J., additional, Nonyane, Molati, additional, Tumba, Nancy, additional, Hermanus, Tandile, additional, Sibeko, Sengeziwe, additional, Mlisana, Koleka, additional, Abdool Karim, Salim S., additional, Williamson, Carolyn, additional, Pinter, Abraham, additional, and Morris, Lynn, additional
- Published
- 2011
- Full Text
- View/download PDF
18. Comparative analysis of expression and secretion of placental leptin in mammals.
- Author
-
Jing Zhao, Kunz, Thomas H., Tumba, Nancy, Schulz, Laura Clamon, Li, Chris, Reeves, Monica, and Widmaier, Eric P.
- Subjects
LEPTIN ,PREGNANCY in animals ,HORMONES ,PLACENTAL hormones ,LABORATORY rats ,BATS - Abstract
Increased plasma level of leptin appears to be a ubiquitous feature of pregnant mammals. The mechanisms by which leptin levels are increased may be species specific, however, with some species upregulating adipose leptin production and others expressing leptin in the placenta. Placental leptin expression was examined in representative species of the two most abundant mammalian orders, Rodentia and Chiroptera, and in cultured human choriocarcinoma (BeWo) cells. Leptin mRNA was expressed in BeWo cells and in placentas of Myotis lucifugus (little brown bat), Eptesicus fuscus (big brown bat), and Rattus norvegicus (laboratory rat), but not the common laboratory mouse Mus musculus. cAMP stimulated secretion of leptin from BeWo cells and also stimulated leptin mRNA expression in the cells. In addition to adipose and placental tissue, leptin transcript in M. lucifugus was detectable in heart, spleen, and liver, but not in lung, brain, and kidney. Hepatic expression was also observed in E. fuscus, but not in mice or rats, and did not appear to result from hepatic fat deposition. Leptin cDNA was cloned and sequenced from M. lucifugus placenta and shared up to 95% homology with other mammalian leptin cDNAs. It is concluded that 1) placental leptin expression and secretion are species-specific traits, 2) placental leptin production represents one of three major mechanisms for achieving high circulating maternal leptin levels during pregnancy, the others being upregulation of adipose leptin production and production of circulating leptin-binding proteins, and 3) hepatic leptin expression in pregnant insectivorous bats may be an adaptation resulting from the presence of extremely low amounts of subcutaneous fat during pregnancy and lactation in these species. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
19. The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection.
- Author
-
Gray, Elin S., Madiga, Maphuti C., Hermanus, Tandile, Moore, Penny L., Wibmer, Constantinos Kurt, Tumba, Nancy L., Werner, Lise, Mlisana, Koleka, Sibeko, Sengeziwe, Williamson, Carolyn, Abdool Karim, Salim S., and Morris, Lynn
- Subjects
- *
HIV infections , *T cells , *SERUM , *MULTIVARIATE analysis , *IMMUNOGLOBULINS - Abstract
An understanding of how broadly neutralizing activity develops in HIV-1-infected individuals is needed to guide vaccine design and immunization strategies. Here we used a large panel of 44 HIV-1 envelope variants (subtypes A, B, and C) to evaluate the presence of broadly neutralizing antibodies in serum samples obtained 3 years after seroconversion from 40 women enrolled in the CAPRISA 002 acute infection cohort. Seven of 40 participants had serum antibodies that neutralized more than 40% of viruses tested and were considered to have neutralization breadth. Among the samples with breadth, CAP257 serum neutralized 82% (36/44 variants) of the panel, while CAP256 serum neutralized 77% (33/43 variants) of the panel. Analysis of longitudinal samples showed that breadth developed gradually starting from year 2, with the number of viruses neutralized as well as the antibody titer increasing over time. Interestingly, neutralization breadth peaked at 4 years postinfection, with no increase thereafter. The extent of cross-neutralizing activity correlated with CD4+ T cell decline, viral load, and CD4+ T cell count at 6 months postinfection but not at later time points, suggesting that early events set the stage for the development of breadth. However, in a multivariate analysis, CD4 decline was the major driver of this association, as viral load was not an independent predictor of breadth. Mapping of the epitopes targeted by cross-neutralizing antibodies revealed that in one individual these antibodies recognized the membrane-proximal external region (MPER), while in two other individuals, cross-neutralizing activity was adsorbed by monomeric gp120 and targeted epitopes that involved the N-linked glycan at position 332 in the C3 region. Serum antibodies from the other four participants targeted quaternary epitopes, at least 2 of which were PG9/16-like and depended on the N160 and/or L165 residue in the V2 region. These data indicate that fewer than 20% of HIV-1 subtype C-infected individuals develop antibodies with cross-neutralizing activity after 3 years of infection and that these antibodies target different regions of the HIV-1 envelope, including as yet uncharacterized epitopes. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
20. Ibogaine administration following repeated morphine administration upregulates myelination markers 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNP) and myelin basic protein (MBP) mRNA and protein expression in the internal capsule of Sprague Dawley rats.
- Author
-
Govender D, Moloko L, Papathanasopoulos M, Tumba N, Owen G, and Calvey T
- Abstract
Ibogaine is a psychedelic alkaloid being investigated as a possible treatment for opioid use disorder. Ibogaine has a multi-receptor profile with affinities for mu and kappa opioid as well as NMDA receptors amongst others. Due to the sparsity of research into ibogaine's effects on white matter integrity and given the growing evidence that opioid use disorder is characterized by white matter pathology, we set out to investigate ibogaine's effects on two markers of myelination, 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNP) and myelin basic protein (MBP). Fifty Sprague Dawley rats were randomly assigned to five experimental groups of n = 10; (1) a saline control group received daily saline injections for 10 days, (2) a morphine control group received escalating morphine doses from 5 to 15 mg/kg over 10 days, (3) an ibogaine control group that received 10 days of saline followed by 50 mg/kg ibogaine hydrochloride, (4) a combination morphine and ibogaine group 1 that received the escalating morphine regime followed by 50 mg/kg ibogaine hydrochloride and (5) a second combination morphine and ibogaine group 2 which followed the same morphine and ibogaine regimen yet was terminated 72 h after administration compared to 24 h in the other groups. White matter from the internal capsule was dissected and qPCR and western blotting determined protein and gene expression of CNP and MBP. Morphine upregulated CNPase whereas ibogaine alone had no effect on CNP mRNA or protein expression. However, ibogaine administration following repeated morphine administration had an immediate effect by increasing CNP mRNA expression. This effect diminished after 72 h and resulted in a highly significant upregulation of CNPase protein at 72 h post administration. Ibogaine administration alone significantly upregulated protein expression yet downregulated MBP mRNA expression. Ibogaine administration following repeated morphine administration significantly upregulated MBP mRNA expression which increased at 72 h post administration resulting in a highly significant upregulation of MBP protein expression at 72 h post administration. These findings indicate that ibogaine is able to upregulate genes and proteins involved in the process of remyelination following opioid use and highlights an important mechanism of action of ibogaine's ability to treat substance use disorders., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Govender, Moloko, Papathanasopoulos, Tumba, Owen and Calvey.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.